Results 311 to 320 of about 290,514 (386)
Some of the next articles are maybe not open access.

Estrogen replacement therapy

International Journal of Gynecology & Obstetrics, 1989
More than 40 million American women are menopausal; another 3.5 million women will be reaching the climacteric age each year for the next 12 years. These women will have a life expectancy of more than 30 years after menopause. In America, there are three widely recognized indications for postmenopausal hormone replacement: vasomotor symptoms ...
openaire   +3 more sources

Estrogen replacement therapy.

JAMA, 1980
Elsewhere in this issue Ross et al (p 1635) report on a retrospective study apparently linking menopausal use of estrogen with an excess risk of breast cancer. In fact, the overall results do not show a significant difference in estrogen use between cases and controls. The significant findings are limited to the subgroup with intact ovaries.
P, Meier, R L, Landau
openaire   +3 more sources

Estrogen replacement therapy.

Obstetrics and gynecology, 1983
Estrogen replacement therapy has been scrutinized closely and the biologic effects of various estrogens have been examined extensively during the past 5 years.1–14 During the early 1960s, estrogens were used liberally in an attempt to perpetuate youth for menopausal women.
J A, Dickinson, A J, Dobson, W F, Forbes
openaire   +3 more sources

Estrogen Replacement Therapy

2014
Menopausal symptoms are common and can be uncomfortable and even debilitating. Estrogen can markedly reduce such symptoms in 900 out of 1,000 women who take it. In a large study, it was found that women who took estrogen have increased risk of breast cancer, leg clots, and nonfatal strokes, although many women in the study were older.
Erik Rifkin, Andrew Lazris
openaire   +1 more source

Estrogen Replacement Therapy: Current Recommendations

Mayo Clinic Proceedings, 1988
Estrogen replacement therapy is effective for the prevention and treatment of postmenopausal osteoporosis and should be offered to all women at high risk for osteoporosis. Such therapy is particularly beneficial for prevention of spinal compression fractures; in addition, it alleviates menopausal symptoms (hot flushes, genitourinary symptoms, and ...
E G, Lufkin   +4 more
openaire   +2 more sources

Estrogen replacement therapy: determinants of persistence with treatment

Obstetrics & Gynecology, 2001
To evaluate the persistence rate for estrogen therapy and to identify its determinants.From the Quebec health insurance database we chose a cohort of 4527 women 35 years and older who received social assistance and were new users of estrogen between January 1989 and December 1997. Incident use was defined by the absence of any dispensed prescription of
D, Pilon, A M, Castilloux, J, LeLorier
openaire   +2 more sources

Estrogen replacement therapy: An overview

American Journal of Obstetrics and Gynecology, 1989
Levels of circulating estrogen fall during the perimenopausal period, resulting in changes in the postmenopausal woman's genitourinary tract, central nervous and cardiovascular systems, skin, and bone. Exogenous estrogen minimizes the benign symptoms and prevents the increased incidence of osteoporosis and atherosclerotic heart disease that accompany ...
openaire   +2 more sources

Estrogen Replacement Therapy And Osteoporosis

Hospital Practice, 1991
Estrogen cannot replace bone that has been lost nor...straighten curvature of the spine or restore lost height. Usually, however, it can arrest the disease's progression.
openaire   +2 more sources

Menopause and Estrogen Replacement Therapy

Psychiatric Clinics of North America, 1989
As America ages the menopausal woman is emerging as a principal focus in the health care system. Research efforts continue to define the mechanism for vasomotor instability, osteoporosis, and new and improved methods of estrogen administration. Though attenuation of symptoms of hot flushes, urogenital atrophy, and prevention of osteoporosis can be ...
openaire   +2 more sources

Estrogen replacement therapy and stroke

Progress in Cardiovascular Diseases, 1995
The results of the 19 studies examining the association between estrogen replacement therapy and cerebrovascular disease are inconsistent. Although all 7 studies of death from stroke found a 20% to 60% reduction in risk among estrogen users relative to nonusers, studies of incident stroke and subarachnoid hemorrhage in particular are conflicting, with ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy